Product Description
Nimodip Medicine is a pharmaceutical-grade tablet that contains Nimodipine as the active ingredient, with a purity of 99%. The medication is intended for oral administration in adults to treat and prevent brain damage resulting from reduced blood flow post subarachnoid hemorrhage. Each tablet typically contains between 30 mg to 60 mg, as directed by a healthcare professional. It is crucial to store this medication at room temperature, away from moisture and direct sunlight, for optimal efficacy. With a CAS No of 66085-59-4 and molecular formula C21H26N2O7, this medication offers therapeutic benefits in specific stroke-related conditions.
FAQs of Nimodip Medicine:
Q: What is the primary use of Nimodip Medicine?
A: Nimodip Medicine is primarily used to treat and prevent brain damage caused by reduced blood flow following a subarachnoid hemorrhage.
Q: How should Nimodip Medicine be stored?
A: Nimodip Medicine should be stored at room temperature, away from moisture and direct sunlight.
Q: What is the recommended dosage of Nimodip Medicine?
A: The dosage of Nimodip Medicine should be as directed by a healthcare professional, typically between 30 mg to 60 mg every 4 hours.
Q: What is the formulation type of Nimodip Medicine?
A: Nimodip Medicine is available in tablet form for oral administration.
Q: Is Nimodip Medicine suitable for all age groups?
A: Nimodip Medicine is suitable for adults.